PROHANCE 0.5 mmol/ml, solution for injection in a pre-filled syringe syringe, 15 ml
Active ingredients: Gadoteridol
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 15 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROHANCE 0,5 mmol/mL, solution injectable en seringue pré-remplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 15 ml
- Marketing authorisation holder
- BRACCO IMAGING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Feb 2001
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61258225CIP73508288CIP133400935082886Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GADOTÉRIDOLsolution | 279,3 mg · 1 mL de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
- syringe, 10 mlCommercialized according to BDPM
- syringe, 17 ml, CIP 3400935082947Commercialized according to BDPM
- syringe, 17 ml, CIP 3400930011867Commercialized according to BDPM
- syringe, 17 ml, CIP 3400930011881Commercialized according to BDPM
- syringe, 17 ml, CIP 3400930219669Commercialized according to BDPM
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.